Mayo, Illumina Forge Bioinformatics Partnership for Genetic Disorder Testing

newtest-ngs-featureMayo Clinic and biotechnology firm Illumina, Inc. will collaborate on next-generation sequencing technology to further Mayo's genetic and genomic research.

Together, the organizations plan to integrate existing services and software tools and employ new, innovative solutions to improve Mayo Clinic’s reporting workflows for researching inherited disease, enabling Illumina to develop an informatics platform and knowledge base that can improve and automate genomic interpretation.

As part of the agreement, Mayo Clinic will implement BaseSpace Clarity LIMS in specific laboratories to provide testing of the tool. BaseSpace Clarity LIMS is a system to provide comprehensive workflow tracking and integration in laboratories. Mayo Clinic will also deploy and provide feedback on its use of BaseSpace Sequence Hub, a cloud-based genomics computing environment for data analysis and management, and BaseSpace Variant Interpreter, a cloud-based interpretation and reporting platform designed to decrease the time and effort required to assess biological insight from genomic data. The software solutions will be piloted by Mayo Clinic to annotate and interpret genetic variants with regard to their potential role in the development and progression of diseases.

"Through this relationship, we'll be able to generate large volumes of genomic information, interrogate the data, and then compare it to what's known about those variants and those genetic aberrations in real time, saving our geneticists time," says William Morice, II, M.D., Ph.D., Chair of Mayo's Department of Laboratory Medicine and Pathology, and President of Mayo Medical Laboratories.

“Mayo Clinic has been at the forefront of advanced medical research and patient care for a long time,” says Sanjay Chikarmane, Senior Vice President and General Manager of Illumina Enterprise Informatics. “BaseSpace Informatics Suite has the ability to provide a cloud-based software solution that can manage, analyze, and interpret data automatically. We’re pleased that our offering will help Mayo Clinic make sense of genomic data faster and more accurately.”

About BaseSpace Informatics Suite
BaseSpace Informatics Suite tools and solutions allow users to manage and process data in one, secure unified system, from laboratory information management and data storage, to analysis and interpretation. This seamless integration between tools and solutions enables users to save time by automating the process from the initial sample intake to getting a report about genomic data, and provides high-quality, accurate information with a fast turnaround time.

About Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumine.

kschrib

Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.